FDA Adverse Event Malfunction Summary report: N

ONETOUCHPING GLUCOSEMGMTSYSTEM

MDR report key: 3111416 · Received May 14, 2013

Report

Report Number
2531779-2013-06338
Event Type
Malfunction
Date Received
May 14, 2013
Report Date
April 16, 2013
Manufacturer
ANIMAS CORPORATION
Product Code
LZG
PMA / PMN Number
K080639
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE PUMP HAS BEEN RETURNED AND EVALUATED BY PRODUCT ANALYSIS ON (B)(4) 2013 WITH THE FOLLOWING FINDINGS: THE BLACK BOX SHOWED LOSS OF PRIME WARNINGS WITH A ZERO LOW FORCE. THE PUMP WAS EXERCISED FOR 24 HOURS WITH A 1 UNIT PER HOUR BASAL PROGRAM. NO LOSS OF PRIME OR PRIME RELATED WARNINGS DUPLICATED. PERFORMED MULTIPLE LOAD STEP FUNCTIONS AND NO FAILURES OR LOSS OF PRIME OBSERVED. FORCE CALIBRATION CHECK PASSES. THE DISPLAY LENS WAS REMOVED AND THE FORCE SENSOR PINS ARE SEATED. THE PUMP CASE WAS REMOVED AND THERE WAS EVIDENCE OF A CRACKED FORCE SENSOR TRACE. THE RETAINED CARTRIDGE WAS EVALUATED BY PRODUCT ANALYSIS ON (B)(4) 2013 WITH THE FOLLOWING FINDINGS: THE RETAINED CARTRIDGE PASSED VISUAL INSPECTION WITH NO DAMAGE OR DEFECTS NOTED IN THE LUER CONNECTION OR O-RINGS. A LEAK TEST WAS PERFORMED WITH NO FAILURES BEING OBSERVED. THERE WERE NO LEAKS OBSERVED FROM THE LUER CONNECTION, O-RINGS, OR ANYWHERE ELSE IN THE CARTRIDGE. (B)(6). DEVICE HISTORY RECORD REVIEW WAS CONDUCTED ON (B)(4) 2013 WITH THE FOLLOWING FINDINGS. ANIMAS HAS CONDUCTED A REVIEW OF THE DEVICE HISTORY RECORD FOR THIS PUMP AND CONFIRMED THAT IT WAS OPERATING WITHIN REQUIRED SPECIFICATIONS AT THE TIME OF RELEASE.

Description of Event or Problem · 1

THE PUMP WAS RETURNED FOR INVESTIGATION. INVESTIGATION REVEALED THAT THERE WAS A CRACKED FORCE SENSOR TRACE. THIS REPORT IS MADE BASED ON RESULTS OF INVESTIGATION COMPLETED ON (B)(4) 2013.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
212627 ONETOUCHPING GLUCOSEMGMTSYSTEM INSULIN INFUSION PUMP LZG ANIMAS CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 12 YR